Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Evolus, Inc. - Common Stock
(NQ:
EOLS
)
5.210
-0.450 (-7.95%)
Streaming Delayed Price
Updated: 1:35 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evolus, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Evolus to Report Fourth Quarter and Year End 2021 Results and Provide Business Update
February 17, 2022
From
Evolus
Via
Business Wire
Evolus Receives Acceptance of Submission in Australia, a Pivotal Step in Approval Process for Nuceiva®
February 08, 2022
From
Evolus
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
February 07, 2022
Gainers Nuvectis Pharma (NASDAQ:NVCT) stock moved upwards by 132.3% to $7.55 during Monday's regular session. The current volume of 17.0 million shares is 2307.5% of...
Via
Benzinga
Evolus to Participate in the Virtual 11th Annual SVB Leerink Global Healthcare Conference
February 02, 2022
From
Evolus, Inc.
Via
Business Wire
41 Biggest Movers From Yesterday
↗
January 27, 2022
Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
January 26, 2022
Gainers Rani Therapeutics Hldgs (NASDAQ:RANI
Via
Benzinga
Evolus Expects Q4 FY21 Sales Better Than Anticipated, Issues FY22 Guidance
↗
January 26, 2022
Evolus Inc (NASDAQ: EOLS) has posted interim Q4 sales of approximately $34.7 million (better than the consensus of $30.87 million), up 68% Y/Y, driven by higher...
Via
Benzinga
Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2021 Net Revenue and Provides 2022 Guidance
January 26, 2022
From
Evolus, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022
↗
January 20, 2022
Upgrades For W.P. Carey Inc (NYSE:WPC), B...
Via
Benzinga
Evolus Expands Board of Directors With Appointment of Digital and Beauty Innovator Brady Stewart
January 05, 2022
From
Evolus
Via
Business Wire
Evolus Joins Nasdaq Biotechnology Index
December 20, 2021
From
Evolus
Via
Business Wire
Evolus Enters Into $125 Million Credit Facility with Pharmakon Advisors
December 14, 2021
From
Evolus, Inc.
Via
Business Wire
4 Stocks Insiders Are Buying
↗
August 26, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 23, 2021
Gainers Cara Therapeutics (NASDAQ:CARA) ...
Via
Benzinga
4 Stocks Insiders Are Buying
↗
August 18, 2021
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go...
Via
Benzinga
Can Evolus Disrupt the Botox Market?
↗
July 03, 2021
This small-cap stock is going after a billion-dollar market.
Via
The Motley Fool
Repeat Doses Of Evolus' Frown Lines Treatment Are Safe, With Decreasing Rates Of Adverse Events
↗
May 12, 2021
Evolus Inc (NASDAQ: EOLS) has announced two newly published peer review studies in Aesthetic Surgery Journal that provide supportive evidence of the safety...
Via
Benzinga
44 Biggest Movers From Yesterday
↗
April 23, 2021
Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares...
Via
Benzinga
Topics
Initial Public Offering
Earnings Scheduled For May 12, 2021
↗
May 12, 2021
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report...
Via
Benzinga
Why Evolus Stock Dived by Almost 19% Today
↗
April 22, 2021
Few are smiling about the company's upcoming share issue.
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Falls 300 Points; Teradata Shares Spike Higher
↗
April 22, 2021
Toward the end of trading Thursday, the Dow traded down 0.89% to 33,834 while the NASDAQ fell 0.71% to 13,850. The S&P also fell, dropping 0.76% to 4,141.60. The U.S. has the...
Via
Benzinga
Topics
Stocks
Mid-Day Market Update: Qualtrics International Jumps After Q1 Results; Evolus Shares Slide
↗
April 22, 2021
Midway through trading Thursday, the Dow traded down 0.26% to 34,047.37 while the NASDAQ rose 0.26% to 13,986.13. The S&P also fell, dropping 0.03% to 4,172.30. The U.S. has...
Via
Benzinga
Topics
Stocks
30 Stocks Moving In Thursday's Mid-Day Session
↗
April 22, 2021
Gainers Teradata Corporation (NYSE: TDC) shares jumped 28.6% to $51.29 after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE: SEAC) gained 19.6...
Via
Benzinga
Mid-Morning Market Update: Markets Down; AT&T Tops Q1 Views
↗
April 22, 2021
Following the market opening Thursday, the Dow traded down 0.38% to 34,006.89 while the NASDAQ fell 0.19% to 13,924.37. The S&P also fell, dropping 0.21% to 4,164.51. The U.S...
Via
Benzinga
Topics
Stocks
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
↗
April 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...
Via
Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
↗
April 22, 2021
Gainers Teradata Corporation (NYSE: TDC) shares rose 29% to $51.45 in pre-market trading after the company raised its Q1 earnings guidance. SeaChange International, Inc. (NYSE:...
Via
Benzinga
6 Stocks Moving In Wednesday's After-Hours Session
↗
April 21, 2021
Gainers Teradata (NYSE: TDC) shares are trading higher after the company announced it raised Q1 EPS guidance above estimates. Kinder Morgan (NYSE: KMI) shares are trading higher...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
